BioHarvest Sciences Inc. ... (BHST)
Bid | 11.93 |
Market Cap | 216.65M |
Revenue (ttm) | 30.17M |
Net Income (ttm) | -12.06M |
EPS (ttm) | -0.69 |
PE Ratio (ttm) | -18.12 |
Forward PE | -316.75 |
Analyst | Buy |
Dividends | n/a |
Ask | 12.32 |
Volume | 23,825 |
Avg. Volume (20D) | 50,207 |
Open | 12.23 |
Previous Close | 12.03 |
Day's Range | 11.84 - 12.72 |
52-Week Range | 4.66 - 12.80 |
Beta | 1.47 |
Ex-Dividend Date | n/a |
About BHST
undefined
Analyst Forecast
According to 0 analyst ratings, the average rating for BHST stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAnalysts project revenue of ... Unlock content with Pro Subscription

3 weeks ago · proactiveinvestors.com
BioHarvest balance sheet gets $14.7m boos, including $11m of new investmentBioHarvest Sciences Inc. (NASDAQ:BHST) has strengthened its finances by pulling in $10.9 million in fresh investment and trimming $3.8 million in debt through a series of deals involving warrants and ...

1 month ago · seekingalpha.com
BioHarvest Sciences Inc. (BHST) Virtual Investor Webinar Call (Transcript)BioHarvest Sciences Inc. (NASDAQ:BHST ) Virtual Investor Webinar Conference September 10, 2025 01:00 PM ET Company Participants Ilan Sobel - Chief Executive Officer Zaki Rakib - Co-Founder, Executive ...

1 month ago · proactiveinvestors.com
BioHarvest Sciences achieves large-scale production of plant-based exosomesBioHarvest Sciences Inc. (NASDAQ:BHST) announced it has successfully produced plant-based exosomes at scale in its proprietary bioreactors, a development the company says represents a breakthrough in ...

2 months ago · seekingalpha.com
BioHarvest Sciences Inc. (BHST) Q2 2025 Earnings Call TranscriptBioHarvest Sciences Inc. (NASDAQ:BHST ) Q2 2025 Earnings Conference Call August 11, 2025 8:00 AM ET Company Participants Bar Dichter - Chief Financial Officer Ilan Sobel - Chief Executive Officer Conf...

2 months ago · newsfilecorp.com
BioHarvest Sciences Reports Second Quarter 2025 Financial ResultsRobust 41% Year-Over-Year Revenue Growth, Driven by Strong Core Capsule and New Product Sales Rehovot, Israel--(Newsfile Corp. - August 11, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ...